• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Gossamer Bio Promotes Richard Aranda to CMO firstwordpharma
    June 22, 2021
    Gossamer Bio, Inc. (Nasdaq: GOSS) today announced that, Richard Aranda, M.D., previously Senior Vice President and Head of Clinical Development, will be promoted to Chief Medical Officer.
  • Gossamer Bio Appoints Sandra Milligan to its Board of Directors firstwordpharma
    June 15, 2021
    Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics today announced the appointment of Sandra Milligan, M.D., J.D., to its Board of Directors.
  • Gossamer Bio secures $230m to support growth and expansion pharmaceutical-technology
    July 26, 2018
    US-based biotechnology company Gossamer Bio has raised $230m in a series B financing round to support its growth and pipeline expansion activities.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service